Pitfalls in demonstrating an endogenous ligand of imipramine recognition sites
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (6) , 945-949
- https://doi.org/10.1016/0006-2952(87)90189-4
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitorsPsychopharmacology, 1986
- [3H]imipramine displacement and 5HT uptake inhibition by tryptoline derivatives: In rat brain 5-methoxytryptoline is not the autacoid for [3H]imipramine recognition sitesEuropean Journal of Pharmacology, 1986
- Tritiated Imipramine Binding Distinguishes Among Subtypes of DepressionArchives of General Psychiatry, 1985
- Tryptamine, a Substrate for the Serotonin Transporter in Human Platelets, Modifies the Dissociation Kinetics of [3H]Imipramine Binding: Possible Allosteric InteractionJournal of Neurochemistry, 1985
- Inhibition of synaptosomal 5‐[3H]hydroxytryptamine uptake by endogenous factor(s) in human bloodFEBS Letters, 1984
- Autacoids for Drug Receptors: A New Approach in Drug DevelopmentAnnals of the New York Academy of Sciences, 1984
- Criteria for receptor sites in binding studiesBiochemical Pharmacology, 1984
- Complex Inhibition of [3H]Imipramine Binding by Serotonin and Nontricyclic Serotonin Uptake BlockersJournal of Neurochemistry, 1983
- Binding of 63H9imimipramine and 63H9desipramine as biochemical tools for studies in depressionNeuropharmacology, 1983
- High-Affinity [ 3 H]Imipramine Binding in Rat Hypothalamus: Association with Uptake of Serotonin But Not of NorepinephrineScience, 1980